A pharmacovigilance study of association between proton pump inhibitor and dementia event based on FDA adverse event reporting system data

Proton pump inhibitor (PPI) was widely used around the world. Studies suggested conflicting results between PPI treatment and dementia event. This study examined the association between six PPI agents and dementia event by mining the US FDA Adverse Event Reporting System (FAERS) database from 2004 t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Bin, Hu, Qiaozhi, Tian, Fangyuan, Wu, Fengbo, Li, Yuwen, Xu, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139970/
https://www.ncbi.nlm.nih.gov/pubmed/34021217
http://dx.doi.org/10.1038/s41598-021-90108-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139970/
https://www.ncbi.nlm.nih.gov/pubmed/34021217
http://dx.doi.org/10.1038/s41598-021-90108-7

Ejemplares similares